SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | n/a |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 743.39 |
| Book Value / Share | 0.87 |
| Price / Book | n/a |
| NCAV ($M) | 560.45 |
| NCAV / Share | 0.66 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.12 |
| Return on Assets (ROA) | 0.08 |
| Return on Equity (ROE) | 0.13 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.60 |
| Current Ratio | 2.72 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,096.84 |
| Assets | 1,279.77 |
| Liabilities | 536.39 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 838.00 |
| Operating Income | 18.38 |
| Net Income | 100.78 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 219.26 |
| Cash from Investing | -291.14 |
| Cash from Financing | 48.66 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 15,554 | 119,074 | 13.06 | |
| 6,455 | 24,338 | 26.52 | |
| 14,928 | 52,600 | 28.38 | |
| 21,753 | 62,037 | 35.06 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABCL – AbCellera Biologics Inc. | ABOS – Acumen Pharmaceuticals, Inc. |
| ABUS – Arbutus Biopharma Corporation | ACAD – ACADIA Pharmaceuticals Inc. |
| ACLX – Arcellx, Inc. |
Financial data and stock pages provided by
Fintel.io